Technique of mesorectal excision in rectal cancer - Still a hot subject?;Technik der mesorektaler exzision beim rektumkarzinom - Immer noch ein aktuelles thema?

Viszeralchirurgie

Volumn 41, Issue 5, 2006, Pages 313-323

  Liersch, Torsten ^a   Langer, C ^a   Ghadimi, B M ^a   Rothe, H ^a   Hess, C F ^a   Becker, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

CAO AIO ARO 94 study; GAST 05 study; Rectal cancer; Total and partial mesorectal excision

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; EXCISION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RECTOSCOPY; RECTUM CANCER; ULTRASOUND;

EID: 33750983383     PISSN: 14353067     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-942269     Document Type: Article

References (70)

1. Andre T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-2351
2. Arbeitgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland in Zusammenarbeit mit dem Robert Koch Institut. Krebs in Deutschland. Häufigkeiten und Trends. ISBN 3-88718-153-0. http://www.rki.de/gbe/krebs/broschuere2002/broschuere2002.htm. 3. Ausgabe. Saarbrücken 2002
3. Becker H, Liersch T. Rektumkarzinom In: Viszeralchirurgie. [Becker H, Encke A, Röher HD] (Hrsg). 2. Auflage. Elsevier GmbH, Urban & Fischer, München 2006; 602-631
4. Cedermark B, Johansson H, Rutqvist LE, Wilking N, Stockholm Colorectal Cancer Study Group. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1995; 75: 2269-2275
5. Crane CH, Skibber JM, Feig BW et al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 2003; 97: 517-524
6. Dunst J, Reese T, Frings S et al. Phase 1 trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002; 20: 3983-3991
7. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23
8. Enker WE, Thaler HT, Cranor ML et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-346
9. Ferlay J, Bray F, Pisani P et al. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2.0. IARC press, Lyon, France 2004 http://www-depdb.iarc.fr/globocan/GLOBOframe.htm
10. Folkesson J, Birgisson H, Pahlmann L, Cedermark B, Glimelius B, Gunnarsson U, Swedish Rectal Cancer Trial. Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-5650
11. Francois Y, Nemoz CJ, Baulieux J et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer. The Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396-2402
12. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum. Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993; 36: 564-572
13. Frykholm GJ, Pahlman L, Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50: 427-434
14. Gerard A, Buyse M, Nordinger B et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomised study of the European Organisation for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208: 606-614
15. Gerard JP, Chapet O, Nemoz C et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen. The Lyon R0-04 phase II trial. J Clin Oncol 2003; 21: 1119-1124
16. Ghadimi BM, Grade M, Difilippantonio MJ et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005; 23: 1826-1838
17. Gunderson LL, Sargent DJ, Tepper JE et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer. A pooled analysis. Int J Radiat Oncol Biol Phys 2002; 54: 386-396
18. Heald RJ, Moran BJ, Ryall RD et al. Rectal cancer. The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899
19. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482
20. Heald RJ, Ryall RDH, Husband E. The mesorectum in rectal cancer surgery. Clue to pelvic recurrence. Br J Surg 1982; 69: 613-616
21. Hermanek P, Heald RJ. Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal? Colorectal Disease 2003; 6: 10-14
22. Hermanek P, Hermanek P, Hohenberger W et al. The pathological assessment of mesorectal excision. Implications for further treatment quality management. Int J Colorectal Dis 2003; 18: 335-341
23. Hermanek P. Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 1999; 42: 559-562
24. Hida J, Yasutomi M, Maruyama T et al. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method. Justification of total mesorectal excision. J Am Coll Surg 1997; 184: 584-588
25. Hofheinz RD, Gerstenberg-Helldorf B von, Wenz F et al. Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 2005; 23: 1350-
26. Holm T, Johansson H, Rutqvist LE, Cedermark B. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Br J Surg 2001; 88: 839-843
27. Jemal A, Tiwari RC, Murray T et al. Cancer Statistics, 2004. CA Cancer J Clin 2004; 54: 8-29
28. Johnston PG. Prognostic markers of local relapse in rectal cancer. Are we any further forward? J Clin Oncol 2006; 24: 4049-4050
29. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646
30. Kapiteijn E, Putter H, van de Velde CJ et al. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 2002; 89: 1142-1149
31. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision. A prospective evaluation of 622 patients. Ann Surg 2004; 240: 260-268
32. Leong AF. Selective total mesorectal excision for rectal cancer. Dis Colon Rectum 2000; 43: 1237-1240
33. Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C. Lymph node status and TS gene expression are prognostic markers in locally advanced rectal cancer after neoadjuvant Fluorouracil-based chemoradiotherapy. J Clin Oncol 2006; 24: 4062-4068
34. Liersch T, Langer C, Jakob C et al. Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or = T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography? Chirurg 2003; 74: 224-234
35. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio VW. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 1998; 124: 612-618
36. M.E.R.C.U.R.Y. Project (Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study). Study Protocol. Study Coordinator I. Daniels, FRCS, Pelican Centre, North Hampshire Hospital, Basingstoke, Hampshire, UK). http://www.pelicancancer.org/researchprojects 2002
37. Marijnen CA, van de Velde CJ, Putter H, van den Brinck M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer. Report of a multicenter randomized trial. J Clin Oncol 2005; 23: 1847-1858
38. Martling A, Holm T, Johansson H, Rutquist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma. Long-term follow-up of a Population-based study. Cancer 2001; 92: 896-902
39. Martling A, Holm T, Rutquist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 2005; 92: 225-229
40. Martling AL, Holm T, Rutquist LE, Moran BJ, Heald RJ, Cedermark B, Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000; 356: 93-96
41. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996; 348: 1605-1610
42. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Macroscopic evaluation of rectal cancer resection specimen. Clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-1734
43. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: A call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-9264
44. Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, Klimstra D, Cohen AM, Minsky BD, Paty PB, Wong WD. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 2006; 24: 4078-4084
45. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998; 227: 157-167
46. Ptok H, Steinert R, Meyer F, Kröll KP, Scheele C, Köckerling F, Gastinger I, Lippert H. Operative Behandlung von Rektumkarzinomen im Vergleich. Onkologische Langzeitergebnisse einer multizentrischen Beobachtungsstudie nach laparoskopisch-assistierter, konvertierter und primär offener Operation. Chirurg 2006; 77: 709-717
47. Quirke P. The pathologist, the surgeon and colorectal cancer get it right because it matters. Prog Pathol 1998; 4: 201-213
48. Quirke P. Training and quality assurance for rectal cancer. 20 years of data is enough. Lancet Oncol 2003; 4: 695-702
49. Quirke P, Durdey P, Dixon M et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 1986; 2: 996-999
50. Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996; 83: 1112-1115
51. Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003; 21: 3098-3104
52. Rödel C, Grabenbauer GG, Schick C et al. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol 2000; 176: 161-167
53. Rödel C, Liersch T, Hermann RM et al. Multicenter phase II trial of the German Rectal Cancer Study Group. Preoperative radiation with concomitant and adjuvant capecitabine and oxaliplatin for rectal cancer. J Clin Oncol 2006, in press
54. Rödel C, Martus P, Papadoupolos T et al. Prognostic significance of tumor regression grading following preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696
55. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740
56. Schmiegel W, Adler G, Frühmorgen P et al. Kolorektales Karzinom. Prävention und Früherkennung in der asymptomatischen Bevölkerung - Vorsorge bei Risikopatienten - Endoskopische Diagnostik. Therapie und Nachsorge von Polypen und Karzinomen. Z Gastroenterol 2000; 38: 49-75
57. Schmiegel W, Pox C, Adler G et al. S3-Leitlinienkonferenz "Kolorektales Karzinom" 2004. Z Gastroenterol 2004; 42: 1129-1177
58. Scott N, Jackson P, Al-Jaberi T et al. Total mesorectal excision and local recurrence. A study of tumor spread in the mesorectum distal to rectal cancer. Br J Surg 1995; 82: 1031-1033
59. Sobin LH, Wittekind C. TNM classification of malignant tumors Springer, Berlin, Heidelberg, New York 2002
60. Soreide O, Norstein J, Fielding LP, Silen W. International standardization and documentation of the treatment of rectal cancer. In: Soreide O, Norstein J (eds). Rectal cancer surgery. Optimisation - standardisation - documentation. Springer, Berlin, Heidelberg, New York 1997; 405-445
61. Steele Jr G, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989; 210: 127-138
62. Sterk P, Kasperk R, Opitz T, Schubert F, Klein P. Vascular organization in the mesorectum. Angiography of rectal resection specimens. Int J Colorectal Dis 2000; 15: 225-228
63. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-987
64. Swedish Rectal Cancer Trial. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in respectable rectal carcinoma. Eur J Surg 1996; 162: 397-402
65. Syk E, Torkzad MR, Blomquist L, Ljungqvist O, Glimelius B. Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 2006; 93: 113-119: 506-507 (authors reply p 507)
66. nd Multidisciplinary Colorectal Cancer Congress. Noordwijk, The Netherlands 2004
67. Van den Brink M, Stiggelbout AM, van den Hout WB, Kievit J, Kranenbarg EK, Marijnen CA, Nagtegaal ID, Rutten HJ, Wiggers T, van de Velde CJ. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004; 22: 3958-3964
68. Wibe A, Carlsen E, Dahl O, Tveit KM, Weedeon-Fekjaer H, Hestvik UE, Wiig JN, on behalf of The Norwegian Rectal Cancer Group. Nationwide quality assurance of rectal cancer treatment. Colorectal Disease 2006; 8: 224-229
69. Wibe A, Moller B, Norstein J et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-866
70. Zaheer S, Pemberton JH, Farouk R et al. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998; 227: 800-811